Enzo Biochem, Inc. (ENZ) Financials

ENZ Assets vs Liabilities
DateAssetsLiabilities
Jan. 31, 2024 99.1 million 28.3 million
Oct. 31, 2023 121.9 million 43.4 million
July 31, 2023 121.9 million 43.4 million
April 30, 2023 72.1 million 53.1 million

ENZ Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
Jan. 31, 2024 -9.0 million 514000
Oct. 31, 2023 -17.6 million 868000
July 31, 2023 -17.6 million 868000
April 30, 2023 -5.7 million 939000

ENZ Net Income

No data available :(

ENZ Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
Jan. 31, 2024 65.2 million - 3.6 million
Oct. 31, 2023 82.4 million - 3.9 million
July 31, 2023 82.4 million 269000 4.1 million
April 30, 2023 2.6 million 247000 14.5 million

ENZ Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
Jan. 31, 2024 50.5 million
Oct. 31, 2023 49.2 million
July 31, 2023 50.0 million
April 30, 2023 49.4 million

ENZ Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
Jan. 31, 2024 25000 580000 5.1 million -
Oct. 31, 2023 573000 502000 23.3 million -
July 31, 2023 254000 502000 27.2 million -
April 30, 2023 666000 975000 4.3 million 7.7 million

ENZ Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
Jan. 31, 2024 8.6 million 4.3 million
Oct. 31, 2023 -19.7 million 5.1 million
July 31, 2023 31.1 million 19.5 million
April 30, 2023 16.1 million 14.5 million

ENZ

Price: $0.31

52 week price:
0.26
1.30

Forward Dividend Yield: 127.47%

Dividend Per Share: 0.40 USD

Earnings Per Share: -0.14 USD

P/E Ratio: -2.07

Exchange: NYQ

Sector: Healthcare

Industry: Diagnostics & Research

Country: United States

Volume: 12788

Ebitda: 111000

Market Capitalization: 15.2 million

Average Dividend Frequency: 4

Years Paying Dividends: 1

Links: